Being prescribed immunoglobulin therapy can bring a long list of questions.
Patients often want to know what immunoglobulin actually is, why their physician prescribed it, whether they will receive IVIG or SCIG, how long treatment takes, whether they can receive it at home, and what insurance will require before treatment begins.
Those questions are understandable because immunoglobulin therapy is not one single treatment experience. There are multiple FDA-licensed intravenous and subcutaneous immune globulin products, and individual products have different indications, concentrations, schedules, and prescribing requirements.
At Mercy Infusion, we help patients navigate the practical steps that come after a physician prescribes therapy, including insurance benefits verification, prior authorization, medication access, treatment-setting coordination, financial-support review, and scheduling.
“Patients often feel better once they understand what the treatment is, why it was prescribed, and what will happen next. Education is an important part of helping people feel prepared for therapy.”
— April Cable, Senior Director of Operations
Have You Been Prescribed Immunoglobulin Therapy?
Mercy Infusion can help coordinate your physician’s order, insurance requirements, medication, and treatment setting.
Learn About IVIG Therapy
Learn About SCIG Therapy
Call 833-594-0124
What Is Immunoglobulin Therapy?
Immunoglobulins are antibodies. They are proteins used by the immune system to recognize and respond to infections and other substances.
Therapeutic immune globulin is produced from donated human plasma that is pooled and processed into purified medication.
Two common forms are:
- IVIG: intravenous immunoglobulin, administered into a vein.
- SCIG: subcutaneous immunoglobulin, administered into tissue underneath the skin.
The FDA currently licenses multiple IVIG and SCIG products. Products should not be assumed to be interchangeable because approved uses and prescribing information vary.
Why Is Immunoglobulin Therapy Prescribed?
The purpose depends on the diagnosis.
For some patients with primary immunodeficiency, immunoglobulin replaces antibodies that the body does not produce effectively. Several IVIG and SCIG products have FDA-approved primary immunodeficiency indications.
For certain neurologic or autoimmune conditions, immunoglobulin may instead be used for its immune-modulating effects.
For example, Hizentra is approved for maintenance therapy in adults with CIDP in addition to its primary immunodeficiency indication, while HYQVIA is approved for primary immunodeficiency and adult CIDP maintenance therapy.
What Is the Difference Between IVIG and SCIG?
The biggest difference is how the medication enters the body.
IVIG goes directly into a vein and generally allows a larger amount of immunoglobulin to be administered during each treatment.
SCIG is delivered beneath the skin and is commonly administered in smaller amounts at more frequent intervals.
Other differences can include:
| IVIG | SCIG |
| Intravenous administration | Subcutaneous administration |
| Requires venous access | Does not require an IV |
| Often larger, less frequent doses | Usually smaller, more frequent doses |
| Often nurse administered | Some patients may self-administer after training |
| Home or clinical setting | Frequently home based |
| Systemic infusion reactions may occur | Local-site reactions are common |
Patients wanting a deeper comparison can read our guide to IVIG vs. SCIG.
Which Is Better: IVIG or SCIG?
Neither is universally better.
The physician considers factors such as:
- Diagnosis
- FDA-approved product indications
- Dose
- Previous treatment response
- Medical history
- Venous access
- Treatment frequency
- Patient preferences
- Insurance requirements
Certain diseases may have more treatment options than others. A product approved for primary immunodeficiency, for example, should not automatically be assumed to be approved for CIDP or another condition.
How Long Does an IVIG Infusion Take?
Many IVIG treatments take several hours, but there is no single standard infusion time.
Duration can depend on:
- Product
- Dose
- Patient weight
- Prescribed infusion rate
- Whether it is the first dose
- Previous tolerance
- Medical risk factors
- Whether treatment is divided over multiple days
The nurse generally follows product-specific and physician-directed infusion-rate instructions.
How Often Is Immunoglobulin Therapy Given?
Frequency depends on the route, product, condition, dose, and treatment plan.
IVIG maintenance treatment may occur every several weeks for some patients.
SCIG is generally administered more frequently, although schedules vary significantly among products.
HYQVIA, for example, uses a facilitated subcutaneous delivery system that differs from conventional SCIG products.
Patients should follow their physician-prescribed schedule rather than comparing their treatment frequency with that of another patient.
What Happens During an IVIG Infusion?
A typical nurse-administered infusion may include:
- Reviewing current symptoms and health changes
- Checking vital signs
- Establishing or assessing IV access
- Starting the infusion at the prescribed rate
- Monitoring for symptoms or reactions
- Adjusting treatment according to physician orders and protocol
- Providing post-infusion instructions
The exact process varies according to the medication and patient.
What Side Effects Can Occur?
Immune globulin products have product-specific adverse reactions, warnings, and precautions.
Patients receiving IVIG may experience symptoms such as:
- Headache
- Fatigue
- Chills
- Nausea
- Dizziness
- Flu-like symptoms
SCIG commonly produces local reactions such as swelling, redness, tenderness, or itching around infusion sites.
Serious hypersensitivity reactions are a recognized risk with both intravenous and subcutaneous immune globulin products. The FDA has specifically advised clinicians and patients regarding hypersensitivity reactions associated with certain immune globulin lots, reinforcing the need for appropriate monitoring and product-specific precautions.
Patients should review the risks of their specific product with their physician and pharmacist.
Can Immunoglobulin Therapy Be Given at Home?
Yes, many appropriate patients receive IVIG or SCIG at home.
CMS describes home infusion as intravenous or subcutaneous administration of drugs or biological products in the home and notes that treatment may involve medications, pumps, tubing, catheters, nursing education, monitoring, and coordination among multiple healthcare organizations.
Home treatment depends on:
- Medical stability
- Prescribed product
- Previous infusion tolerance
- Required monitoring
- Home environment
- Nursing availability
- Physician direction
- Insurance authorization
Patients can learn more about who qualifies for home infusion.
What If I Prefer an Infusion Center?
That may also be an option.
An infusion suite may be appropriate for patients who:
- Prefer a clinical environment
- Are beginning a new treatment
- Require closer monitoring
- Have previously experienced reactions
- Are not eligible for home infusion
Mercy provides both home infusion and care through its Artesia infusion suite when appropriate.
Will Insurance Cover Immunoglobulin Therapy?
Coverage varies by health plan.
Insurers may require:
- Confirmed diagnosis
- Prior authorization
- Clinical documentation
- Diagnostic testing
- Previous treatment history
- A preferred immune globulin product
- An approved provider
- A specific site of care
Medical appropriateness and insurance approval are separate decisions.
Mercy helps coordinate benefits verification and prior authorization through our specialty medication intake process.
What If Insurance Denies My IVIG?
A denial does not necessarily mean the process is over.
Depending on the reason, the next step may involve:
- Correcting missing information
- Providing additional clinical documentation
- Reviewing preferred-product requirements
- Changing an authorized treatment setting when clinically appropriate
- Requesting reconsideration or appeal
Read our complete guide to what happens when insurance denies a specialty medication.
Is Financial Assistance Available?
Potentially.
Once insurance coverage and expected patient responsibility are understood, patients may be able to explore:
- Manufacturer copay programs
- Manufacturer patient assistance programs
- Charitable foundations
- Other eligible financial-support resources
CMS confirms that pharmaceutical manufacturers may operate patient assistance programs that provide financial support or donated medication to qualifying individuals.
Learn more about copay assistance and financial assistance for specialty medications.
Frequently Asked Questions About Immunoglobulin Therapy
Is immunoglobulin therapy chemotherapy?
No. Immunoglobulin therapy consists of antibodies derived from human plasma and is not chemotherapy.
Does immunoglobulin suppress the immune system?
Its effects depend on why it is prescribed. For primary immunodeficiency, immunoglobulin provides antibody replacement. In selected autoimmune or neurologic conditions, it may alter or regulate immune activity.
Does IVIG require an IV every time?
Many treatments use peripheral IV access, although the appropriate access method depends on the treatment plan and patient.
Can SCIG be self-administered?
Certain patients may self-administer prescribed SCIG after appropriate education, training, and clinical approval.
Can I switch from IVIG to SCIG?
Some patients can. The physician must determine whether an appropriate SCIG product is indicated and prescribe the correct dose and schedule.
Is IVIG lifelong?
It depends on the diagnosis. Some patients require ongoing replacement or maintenance treatment, while others receive shorter treatment courses.
Get Help Navigating Immunoglobulin Therapy
Mercy Infusion helps coordinate:
- Physician prescriptions
- Insurance verification
- Prior authorization
- IVIG and SCIG access
- Home infusion
- Infusion-suite treatment
- Nursing
- Copay and financial-assistance review
- Ongoing treatment scheduling
Learn About IVIG Therapy
See How the Intake Process Works
Call 833-594-0124
About the Author
April Cable, Senior Director of Operations
April Cable has more than 35 years of experience in specialty pharmacy billing, reimbursement, operations, and patient access. She helps patients navigate insurance benefits, prior authorization requirements, financial-support programs, and specialty medication onboarding while coordinating with prescribing providers, insurers, pharmacists, and clinical teams.
This article is intended for general educational purposes and does not determine whether immunoglobulin therapy is appropriate for an individual patient. Treatment decisions must be made by a qualified physician.
